Cronos Group (CRON) to Release Earnings on Thursday

Key Points

• Cronos Group is set to release its Q2 2025 earnings report on August 7th, with expectations of a loss of $0.02 per share and revenue of $45.73 million.
• In its last earnings announcement on May 8th, Cronos reported a net revenue of $33.62 million, which was below analysts' expectations of $45.44 million.
• An institutional investor, Jones Financial Companies Lllp, increased its stake in Cronos Group by 291.6%, highlighting growing interest in the company's stock.

Cronos Group (NASDAQ:CRON - Get Free Report) is expected to post its Q2 2025 quarterly earnings results before the market opens on Thursday, August 7th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $45.73 million for the quarter.

Cronos Group (NASDAQ:CRON - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.01. Cronos Group had a net margin of 39.69% and a negative return on equity of 0.07%. The firm had revenue of $33.62 million during the quarter, compared to analyst estimates of $45.44 million. On average, analysts expect Cronos Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cronos Group Stock Up 2.3%

CRON traded up $0.05 on Monday, reaching $2.00. 733,421 shares of the company traded hands, compared to its average volume of 1,602,951. Cronos Group has a one year low of $1.60 and a one year high of $2.46. The company has a market cap of $769.44 million, a P/E ratio of 15.35 and a beta of 1.01. The firm has a fifty day simple moving average of $1.99 and a two-hundred day simple moving average of $1.93.

Hedge Funds Weigh In On Cronos Group

Large investors have recently added to or reduced their stakes in the stock. Jones Financial Companies Lllp raised its holdings in Cronos Group by 291.6% during the first quarter. Jones Financial Companies Lllp now owns 65,099 shares of the company's stock worth $118,000 after purchasing an additional 48,476 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Cronos Group by 84.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,076,405 shares of the company's stock worth $1,948,000 after purchasing an additional 493,161 shares in the last quarter. Finally, Envestnet Asset Management Inc. acquired a new position in shares of Cronos Group during the 2nd quarter worth $36,000. 8.71% of the stock is currently owned by institutional investors and hedge funds.

Cronos Group Company Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.